Journal article
Associations between Adiponectin and the Development of Diabetes in Rheumatoid Arthritis
The journal of clinical endocrinology and metabolism, Vol.109(10), pp.e1839-e1846
01/08/2024
DOI: 10.1210/clinem/dgae010
PMCID: PMC11403312
PMID: 38189426
Abstract
We evaluated associations between adiponectin and the risk of diabetes among patients with rheumatoid arthritis (RA), a systemic inflammatory disease associated with metabolic disturbance.
This prospective cohort study included adults with RA from the Veteran's Affairs Rheumatoid Arthritis Registry. Adiponectin and inflammatory cytokines/chemokines were measured at enrollment on stored serum samples. Adiponectin levels were categorized and clinical variables were described across categories (<10 μg/mL; 10-40 μg/mL; > 40 μg/mL. Multivariable Cox proportional hazard models evaluated associations between adiponectin and incident diabetes adjusting for age, sex, race, smoking status, body mass index (BMI), disease-modifying therapy use, calendar year, and comorbidity. Testing for modification of effect in the context of elevated cytokines/chemokines was performed.
Among 2595 patients included in the analysis, those with adiponectin levels >40 μg/mL (N = 379; 15%) were older and had lower BMI. There were 125 new cases of diabetes among 1,689 patients without prevalent disease at enrollment. There was an inverse association between adiponectin and incident diabetes, however, the association was positive among patients with adiponectin levels >40 μg/mL. Patients with levels >40 μg/mL were at higher risk compared to those with levels 10-40 μg/mL [HR: 1.70 (1.34,2.16) p < 0.001]. Those with adiponectin levels >40 μg/mL had significantly higher levels of inflammatory cytokines with evidence of a modified effect of adiponectin on diabetes risk in the setting of inflammation.
The relationship between adiponectin and incident diabetes risk is U-shaped in RA. Patients with very high adiponectin levels have greater systemic inflammation and an altered relationship between adiponectin and diabetes risk.
Details
- Title: Subtitle
- Associations between Adiponectin and the Development of Diabetes in Rheumatoid Arthritis
- Creators
- Joshua F Baker - University of PennsylvaniaBryant R England - University of Nebraska Medical CenterKatherine D Wysham - University of Washington School of MedicineBrian Sauer - University of UtahAmy M Joseph - St. Louis VA Medical CenterAleksander Lenert - VA Iowa City Health Care System, Iowa City, IAPunyasha Roul - University of Nebraska Medical CenterRui Xiao - University of PennsylvaniaRachel Gillcrist - Philadelphia VA Medical CenterTate Johnson - University of Nebraska Medical CenterGrant W Cannon - University of UtahMichael Duryee - University of Nebraska Medical CenterGeoffrey M Thiele - University of Nebraska Medical CenterTed R Mikuls - University of Nebraska Medical Center
- Resource Type
- Journal article
- Publication Details
- The journal of clinical endocrinology and metabolism, Vol.109(10), pp.e1839-e1846
- Publisher
- The Endocrine Society
- DOI
- 10.1210/clinem/dgae010
- PMID
- 38189426
- PMCID
- PMC11403312
- ISSN
- 0021-972X
- eISSN
- 1945-7197
- Grant note
- name: Veterans Affairs VA, award: I01 CX001703; name: Rehabilitation Research & Development, award: I01 CX003644; name: VA CSR&D, award: CX002203; name: VA CSR&D, award: CX002351; DOI: 10.13039/100007496, name: VA BLRD, award: BX004660; DOI: 10.13039/100000005, name: Department of Defense, award: PR200793; DOI: 10.13039/100000057, name: National Institutes of General Medical Sciences, award: U54 GM115458
- Language
- English
- Electronic publication date
- 01/08/2024
- Academic Unit
- Immunology; Internal Medicine
- Record Identifier
- 9984544958402771
Metrics
19 Record Views